Chief Executive Officer
Dr. Garry A. Neil serves as Chief Executive Officer and Board member of Avalo Therapeutics, Inc., a clinical-stage biotech company focused on IL-1β-based therapies for immune-mediated inflammatory diseases. He previously served as Chairman before transitioning the role to Michael Heffernan in March